Deciphering the molecular mechanism of the metabolic and epigenetic regulations in cancer could pave the way for therapeutic intervention, and the recent emerging evidences have revealed the essential regulatory role of mTOR complexes in metabolic reprogramming, the responsibility to microenvironments, and the subsequent epigenetic changes, which can result in cell survival in harsh metabolic conditions and provide therapeutic opportunities in cancer. Here, MTOR is linked to cancer.